期刊文献+

阿托伐他汀对家兔动脉粥样硬化血管细胞粘附分子-1基因表达的影响 被引量:5

Effects of atorvastatin on expression of VCAM-1 in atherosclerotic rabbits
下载PDF
导出
摘要 目的探讨家兔动脉粥样硬化病变中血管细胞粘附分子-1(VCAM-1)的表达和阿托伐他汀的抗动脉粥样硬化作用。方法24只大耳白兔随机分为常规饲料组、胆固醇饲料组和阿托伐他汀组,饲养16周。实验前后检测(血清胆固醇TC)、甘油三酯(TG)、低密度脂蛋白(LDL),采用免疫组化和逆转录多聚酶链式反应(PCR)方法测定主动脉壁VCAM-1阳性表达百分比和mRNA的表达。结果阿托伐他汀显著降低TC和LDL水平(P<0.01)。胆固醇饲料组和阿托伐他汀组病变局部VCAM-1的阳性染色百分比和mRNA的表达量明显高于对照组(P<0.01),但阿托伐他汀组动脉粥样硬化病理改变较胆固醇饲料组明显减轻,VCAM-1阳性染色百分比及mRNA的表达量较胆固醇饲料组明显降低(P<0.01)。结论动脉粥样硬化的发生伴有血管细胞粘附分子的高度表达。阿托伐他汀不但有调脂作用,而且具有抑制粘附分子和抗动脉粥样硬化的作用。 Objective To investigate the expression of VCAM-1 in atherosclerotic rabbits and effects of atorvastatin in anti atherosclerosis. Methods Twenty four rabbits were randomly divided into control,cholesterol diet.and atorvastatin group,which were fed for 16 weeks. Serum TC ,TG,LDL were measured in 0 and 16 weeks in the three groups. After 16 weeks, the aortas were harvested for pathologic morphology observation,immunohistochemistry analysis of VCAM-1 positive percentage and the measurement of VCAM-1 mRNA using reverse transcription-polymerase chain reaction(RT-PCR) were performed. Results Atorvastatin greatly reduced TC and LDL (P〈0.01). Atherosclerosis was formed in cholesterol diet and atorvastatin group ,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA in cholesterol diet and atorvastatin group were higher than control (P〈 0.01 ),but pathologic changes .intima thickness and intima/medium thickness ratio(I/M ) in atorvastatin group reduced than cholesterol diet group(P〈0. 01 ) ,the expressions of VCAM-1 and the measurement of VCAM-1 mRNA were lower than cholesterol diet group (P 〈 0. 01 ). Conclusions VCAM-1 can be excessively expressed in atherosclerosis. Atorvastatin not only reduces cholesterole but also inhibits excessive expression of VCAM-1 and has the effect of anti-atherosclerosis.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2005年第4期300-302,i0001,共4页 Journal of Apoplexy and Nervous Diseases
关键词 动脉粥样硬化 阿托伐他汀 血管细胞粘附分子-1 Atherosclerosis, Atorvastatin Vascular cell adhension molecule-1
  • 相关文献

参考文献6

  • 1Fang L,Wei H,Mak KH,et al. Marker of low-grade inflammation and soluble cell adhension molecules in Chinese patients with coronary artery disease[J]. Cardiol,2004,20(14) :1433-1438.
  • 2Funatsn T,Kakuta H ,Tanaka H,et al. Atorvastatin(lipitor);a review of its pharmacological and clinical profile[J]. Nippon Yakurigaku Zasshi, 2001,117 ( 1 ): 65-69.
  • 3LiH,Cybulsky MI,Gimbrone MA Jr,et al. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma [J]. Pathol, 1993,143: 1551-1559.
  • 4Anne Hackman,Yasunori Abe. Levels of soluble adhesion in patients with dyslipidemia circulation[J]. 1996,93:1334-1338.
  • 5冯宗忱.动脉粥样硬化——血管壁的慢性炎症[J].中华心血管病杂志,2005,33(5):393-394. 被引量:66
  • 6Cannon CP,Braunwald E,McCabe CH,et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators, intensive versus moderate lipid lowering with statin after acute coronary syndromes[J]. N Engl J Med, 2004,350 : 1495-1504.

共引文献65

同被引文献122

  • 1文川,徐浩,黄启福,陈可冀.活血中药对ApoE基因缺陷小鼠血脂及动脉粥样硬化斑块炎症反应的影响[J].中国中西医结合杂志,2005,25(4):345-349. 被引量:134
  • 2马涛,凌树才,倪衡建.一氧化氮对体外培养的胚鼠脑干5-羟色胺能神经元生长发育的影响[J].神经解剖学杂志,2006,22(3):323-327. 被引量:4
  • 3Haria M,McTavish D.Pravastatin:a reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease[J].Drugs,1997,53:299-336.
  • 4Sacks F M,Pfefer M A,Moye L A,et al.The effect of pravastation on coronary events after myocardial infarction in patients with average cholesterol levels[J].N Engl J Med,1996,335:1001-1009.
  • 5Smilde T J,van Wissen S,Wollersheim H,et al.Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in fami1ial hypercholesterolaemia(ASAP):a prospective,randomized,double-blind trial[J].Lancet,2001,357:577-581.
  • 6Rizzo M,Berneis K.Who needs to care about small,dense low-density lipoproteins[J].Int J Clin Pract,2007,61:1949-1956.
  • 7Ali F,Hamdulay S S,Kinderlerer A R,et al.Statin-mediated cytoprotection of human vascular endothelial cells:a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1[J].J Thromb Haemost,2007,5:2537-2546.
  • 8Szmitko P E,Verma S.C-reactive protein and the metabolic syndrome:useful addition to the cardiovascular risk profile[J].J Cardiome-tab Syndr,2006,1:66-69.
  • 9Yusuf S,Sleight P,Pogue J,et al.Effects of an angiotensin2-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients.The heart outcomes prevention evaluation study in vestigators[J].N Engl J Med,2000,342:145-153.
  • 10Tanous D,Brasen J H,Choy K,et al.Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization[J].Atherosclerosis,2006,189 (2):342-349.

引证文献5

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部